Correlation Between Enfusion and Auddia
Can any of the company-specific risk be diversified away by investing in both Enfusion and Auddia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and Auddia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and Auddia Inc, you can compare the effects of market volatilities on Enfusion and Auddia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of Auddia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and Auddia.
Diversification Opportunities for Enfusion and Auddia
Pay attention - limited upside
The 3 months correlation between Enfusion and Auddia is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and Auddia Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Auddia Inc and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with Auddia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Auddia Inc has no effect on the direction of Enfusion i.e., Enfusion and Auddia go up and down completely randomly.
Pair Corralation between Enfusion and Auddia
Given the investment horizon of 90 days Enfusion is expected to generate 0.4 times more return on investment than Auddia. However, Enfusion is 2.52 times less risky than Auddia. It trades about 0.2 of its potential returns per unit of risk. Auddia Inc is currently generating about -0.08 per unit of risk. If you would invest 916.00 in Enfusion on August 29, 2024 and sell it today you would earn a total of 86.00 from holding Enfusion or generate 9.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enfusion vs. Auddia Inc
Performance |
| Timeline |
| Enfusion |
| Auddia Inc |
Enfusion and Auddia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enfusion and Auddia
The main advantage of trading using opposite Enfusion and Auddia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, Auddia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auddia will offset losses from the drop in Auddia's long position.| Enfusion vs. ON24 Inc | Enfusion vs. Paycor HCM | Enfusion vs. E2open Parent Holdings | Enfusion vs. Braze Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |